Abstract

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 3

Category: Advanced materials and nanotechnology applications

Advances in the programmable self-assembly of

DNA hydrogel used for drug delivery

Gary Q. Yanga* Weibin Caib, Yujun Wangc

a
College of Bioscience and Bioengineering, Jiangxi Agricultural University, Nanchang,

Jiangxi, 330045, P. R. China.

b
School of Chemical and Environmental Engineering, China University of Mining and

Technology, Beijing 100083, P. R. China.

c
Department of Chemical Engineering, Tsinghua University, Beijing 100084, P. R. China.

*
*Corresponding author. Email: [email protected]
Abstract

Cancer is the deadliest disease for human beings and every year it may cause millions of deaths

globally. Traditional small-molecule drug administration often requires frequent administration

or high drug dosage to realize therapeutic efficacy due to nonspecific targeting. It often incurs

systemic adverse reaction, therefore lowering overall effects and patient compliance. The

emergence of immunotherapy and gene therapy, which involves functional biomolecules of

DNA, RNA and proteins, has presented new challenges for in vivo drug delivery. Naked

nucleic acids and proteins have short serum half-lives because of their susceptibility to

enzymatic degradation, and cell transfection efficiency is rather low. In addition, the biological

activity of protein can be readily damaged during carrier encapsulation. Therefore, it is

essential to develop active and effective carriers for the controllable delivery of small-molecule

and biomolecule drugs. Researchers have developed numerous targeted drug delivery systems

(DDSs) due to the rapid progress of drug vectors including nanoparticles, polymers and

liposomes, but these synthetic materials have poor degradability and low biocompatibility.

DNA hydrogels are comprised of hydrophilic polymeric networks of crosslinked DNA chains.

For their properties of good degradability and high biocompatibility in addition to porosity,

sequence programmability, tunable mechanical properties, controlled phase transformation and

simple preparation, extensive researches have been performed to construct DDS with DNA

hydrogels via programmable DNA-aid self-assembly for targeted drug release. To figure out

1
the advancement trend of the self-assembly techniques and keep pace with its recent rapid

advancements, it is essential to provide an overview of its past and recent progress. In the

review article, we first present the techniques researchers used to construct various hydrogels

made of solely DNA strands via programmable DNA-aided self-assembly. Then we present the

techniques that researchers used to assemble MFs with one or more additional type of

construction material, e.g., inorganic nanoparticle or polymers (including RNA, protein, etc.),

in addition to DNA strands for the purpose of endowing the DDS with improved or additional

properties/functions (e.g., designability, programmability, addressability, tunability and binding

ability, reversibility of assembly, transfection, multiple payload loading, drug-loading capacity,

cell internalization, biosafety, immunocompatibility, nuclease-resistant stability, stimuli-

responsibility, therapeutic efficacy, spatio-temporal controlled delivery, cancer dual/multiple

targeting, etc.). Here the additional construction materials may also classified into two

categories. The first one is purely used for construction purposes. The other one have

additional functions, e.g., tumor cell-targeting, stimuli-response, or themselves being drugs.

From the advancing trend of DNA hydrogel self-assembly nanotechniques, we anticipate that in

the future researchers will combine more materials with DNA strands to assemble more

complex and powerful DNA hydrogels and incorporate more functional components to endow

the DDS with improved or additional properties/functions, contributing to cancer prevention.

You might also like